Search

Search Results

1. The EANM-SNMMI guideline on the role of [18F]FDG-PET/CT in breast cancer: Important milestones and perspectives for the future

   Elif Hindié in European Journal of Nuclear Medicine and Molecular Imaging

   Article 13 May 2024

2. ASCO 2023: highlights in breast cancer

   The 2023 annual meeting of the American Society of Clinical Oncology (ASCO) was again held in June 2023 in Chicago. While not immediately practice...

   Rupert Bartsch in memo - Magazine of European Medical Oncology

   Article Open access 05 December 2023

3. Value of [¹⁸F]AlF-NOTA-FAPI-04 PET/CT for differential diagnosis of malignant and various inflammatory lung lesions: comparison with [¹⁸F]FDG PET/CT

   Objective

   Uptake of the imaging tracers [ ¹⁸ F]AlF-NOTA-FAPI-04 and [ ¹⁸ F]FDG varies in some inflammatory lesions, which may result in false-positive...

   Kailin Qiao, Xueting Qin, ... Yuchun Wei in European Radiology

   Article 05 September 2023
   

4. Diagnostic performance of prospective same-day 18F-FDG PET/MRI and 18F-FDG PET/CT in the staging and response assessment of lymphoma

   Background

   Accurate staging and response assessment are essential for prognosis and to guide treatment in patients with lymphoma. The aim of this...

   Vijay Mistry, Justin R. Scott, ... Greg Hapgood in Cancer Imaging

   Article Open access 24 January 2023
   

5. Clinical practice guidelines for high-resolution breast PET, 2019 edition

   Breast positron emission tomography (PET) has had insurance coverage when performed with conventional whole-body PET in Japan since 2013. Together...

   Yoko Satoh, Masami Kawamoto, ... Keiichiro Yoshinaga in Annals of Nuclear Medicine

   Article Open access 25 January 2021

6. Whole-body tumor burden in PET/CT expert review

   Introduction

   PET/CT whole-body tumor burden (WBTB), as a measure for overall burden of cancer, has been shown bear a strong correlation with...

   Dihego F. Santos, Maria Emilia Takahashi, ... Elba Etchebehere in Clinical and Translational Imaging

   Article 05 August 2022
   

7. Recent topics of the clinical utility of PET/MRI in oncology and neuroscience

   Since the inline positron emission tomography (PET)/magnetic resonance imaging (MRI) system appeared in clinical, more than a decade has passed. In...

   Yuji Nakamoto, Kazuhiro Kitajima, ... Kenji Hirata in Annals of Nuclear Medicine

   Article 27 July 2022

8. [⁶⁸Ga]Ga-FAP-2286, a novel promising theragnostic approach for PET/CT imaging in patients with various type of metastatic cancers

   Background

   Fibroblast activation protein (FAP) has emerged as a promising target for diagnosis and therapeutic intervention due to high expression and...

   Seyedeh Somayyeh Banihashemian, Ghasemali Divband, ... Mohammad Esmaeil Akbari in European Journal of Nuclear Medicine and Molecular Imaging

   Article 20 February 2024
   

9. Staging of breast cancer in pregnancy with ultralow dose [18F]-FDG-PET/CT

   Kirsten Korsholm, Ramune Aleksyniene, ... Barbara Malene Fischer in European Journal of Nuclear Medicine and Molecular Imaging

   Article 12 December 2022
   

10. Diagnostic performance of whole-body [¹⁸F]FDG PET/MR in cancer M staging: A systematic review and meta-analysis

    Objectives

    To calculate the pooled diagnostic performances of whole-body [ ¹⁸ F]FDG PET/MR in M staging of [ ¹⁸ F]FDG-avid cancer entities.

    ...

    Seyed Ali Mirshahvalad, Andres Kohan, ... Patrick Veit-Haibach in European Radiology

    Article 03 August 2023
    

11. Prediction of pathological complete response after neoadjuvant chemotherapy in breast cancer: comparison of diagnostic performances of dedicated breast PET, whole-body PET, and dynamic contrast-enhanced MRI

    Purpose

    To compare the diagnostic performance of ring-type dedicated breast PET (dbPET), whole-body PET (WBPET), and DCE-MRI for predicting...

    Yukiko Tokuda, Masahiro Yanagawa, ... Noriyuki Tomiyama in Breast Cancer Research and Treatment

    Article 17 March 2021
    

12. FAPI PET uptake patterns after invasive medical interventions: a single center retrospective analysis

    Purpose

    Fibroblast activation protein (FAP)-inhibitor (FAPI)-PET tracers allow imaging of the FAP-expressing cancer associated fibroblasts (CAF) and...

    Peter George Maliha, Masatoshi Hotta, ... Jeremie Calais in European Journal of Nuclear Medicine and Molecular Imaging

    Article 16 May 2024
    

13. Prognostic significance of ⁶⁸ Ga-FAPI PET/CT in patients with bone metastases in various cancers

    Objective

    This study aimed to compare ¹⁸ FDGPET/CT in patients who develop bone metastases due to various cancers and to investigate the prognostic...

    Hacı Arak, Umut Elboga, ... Aydın Aytekin in Annals of Nuclear Medicine

    Article 30 April 2024
    

14. Radiolabeled FAP inhibitors as new pantumoral radiopharmaceuticals for PET imaging: a pictorial essay

    Fibroblast activation protein (FAP)-targeted radiopharmaceuticals recently emerged as potential pantumoral agent for PET imaging. FAPi PET provides...

    Lighea Simona Airò Farulla, Emre Demirci, ... Francesco Ceci in Clinical and Translational Imaging

    Article 03 August 2022
    

15. The synergistic effect of PET/MRI in whole-body oncologic imaging: an Expert Review

    Purpose

    Positron emission tomography (PET)/magnetic resonance imaging (MRI) is a hybrid imaging modality that combines MRI and PET imaging into a...

    Felipe S. Furtado, Mina Hesami, ... Onofrio A. Catalano in Clinical and Translational Imaging

    Article 13 July 2023
    

16. PET imaging in the psoriasis and psoriatic arthritis field: un update

    Purpose

    Psoriasis is a chronic autoimmune inflammatory disease that affects skin and nails but may also involve further sites of clinical or...

    Maria Ricci, Silvia Scriffignano, ... Ennio Lubrano in Clinical and Translational Imaging

    Article 10 May 2024
    

17. PET/MRI imaging in neuroendocrine neoplasm

    Molecular imaging plays a vital role in the management of neuroendocrine neoplasms (NENs). Somatostatin receptor (SSTR) PET is critical for...

    Mayur K. Virarkar, Matthew Montanarella, ... Priya Bhosale in Abdominal Radiology

    Article 16 December 2022
    

18. Advances of radiolabeled GRPR ligands for PET/CT imaging of cancers

    GRPR is a type of seven-transmembrane G-protein coupled receptor that belongs to the bombesin protein receptor family. It is highly expressed in...

    Yuze Ma, Feng Gao in Cancer Imaging

    Article Open access 26 January 2024
    

19. Heterogeneity of estrogen receptor based on ¹⁸F-FES PET imaging in breast cancer patients

    Purpose

    Although there are some original articles related to the application of ¹⁸ F-FES imaging in breast cancer patients, the heterogeneity of...

    Wanting Hao, Yaming Li, ... Xuena Li in Clinical and Translational Imaging

    Article 06 August 2021
    

20. The impact of geriatric characteristics and comorbidities on distant metastases and other cause mortality in older women with non-metastatic breast cancer treated with primary endocrine therapy

    Introduction

    In recent years, primary surgical treatment of older women with non-metastatic breast cancer has decreased in favor of primary endocrine...

    M. E.C. Waaijer, A. A. Lemij, ... N. A. de Glas in Breast Cancer Research and Treatment

    Article Open access 21 July 2023